Evidence map›Paper›PMID 40454573›Full record

ReviewDevelopment (Cambridge, England)2025

Feto-placental blood vessel development.

Jacinta I Kalisch-Smith

Abstract readReview
In one paragraph

Review in Development (Cambridge, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. The human placenta development and anatomy.Archives of gynecology and obstetrics · 2026
    Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Jacinta I Kalisch-SmithInstitute for Developmental and Regenerative Medicine, Department of Physiology, Anatomy and Genetics, The University of Oxford, Old Road Campus, Headington, Oxford OX3 7TY, UK.ORCID 0000-0002-5071-3805

Funding

BHF Centre of Research Excellence, Oxford RE/18/3/34214
6 · The paper itself

Abstract

Development of the feto-placental blood vessels (human), or chorio-allantoic vasculature (mouse), is crucial for embryonic and fetal survival. While the processes governing embryonic vascular development are fairly well established, our understanding of feto-placental vascular formation is lagging decades behind. There are many unanswered questions in the field regarding potential progenitor populations, the timing of arterio-venous differentiation, the molecular cues that induce angiogenesis and the sources of these factors. In humans, particularly, there is little information on first-trimester placental vascular development or what pathologies may be caused by poor vascularisation. This Review discusses known processes of feto-placental blood vessel development in mice and humans, including their progenitors and derivatives (with their molecular markers), genetic knockouts and associated vascular phenotypes, trophoblast-endothelial signalling, co-occurrence with embryonic heart defects, genetic tools and imaging modalities targeting these vessels and pathologies that are impacted by vascular defects. Recent insight into early human placental vascularisation suggests it is more similar to the mouse than previously appreciated.

Indexed as

Blood VesselsFetusNeovascularization, PhysiologicPlacentaAnimalsFemaleHumansMicePregnancyAllantoisCongenital heart defectsEndothelial cellsFeto–placental blood vesselsPregnancy complications

Identifiers

PMID40454573
PMCPMC12243455

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.